Faisal Raza works at the School of Pharmacy at Shanghai Jiao Tong University (SJTU), China. He received his M.S. degree in Pharmaceutics from China Pharmaceutical University (CPU), Nanjing, China, in 2019. His research focuses on the development of stimuli-responsive nanomedicine for the treatment of cancer. Such nanomedicine is based on novel biomimetic nanotechnologies derived from various cell sources and used for various biomedical applications with a particular focus on cancer drug delivery.